Interleukin-15 and NK1.1+ cells provide innate protection against acute Salmonella enterica serovar typhimurium infection in the gut and in systemic tissues

Infection and Immunity

Volumn 77, Issue 1, 2009, Pages 214-222

  Ashkar, Ali A ^a   Reid, Sarah ^a   Verdu, Elena F ^a   Zhang, Kun ^b   Coombes, Brian K ^a,b  

^a MCMASTER UNIVERSITY   (Canada)

^b MCMASTER UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOVIRUS VECTOR; INTERLEUKIN 15;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL FUNCTION; CONTROLLED STUDY; CYTOKINE PRODUCTION; FEMALE; GENE OVEREXPRESSION; INFECTION SENSITIVITY; INNATE IMMUNITY; MOUSE; NATURAL KILLER CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; RETICULOENDOTHELIAL SYSTEM; SALMONELLA ENTERICA; SALMONELLA TYPHIMURIUM; SEROTYPE; TYPHOID FEVER;

ANIMALS; ANTIGENS, LY; CECUM; COLON; FEMALE; INTERLEUKIN-15; INTESTINES; KILLER CELLS, NATURAL; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MONONUCLEAR PHAGOCYTE SYSTEM; NK CELL LECTIN-LIKE RECEPTOR SUBFAMILY B; SALMONELLA INFECTIONS, ANIMAL; SALMONELLA TYPHIMURIUM;

EID: 58449085830     PISSN: 00199567     EISSN: 10985522     Source Type: Journal    
DOI: 10.1128/IAI.01066-08     Document Type: Article

References (48)

1. Barthel, M., S. Hapfelmeier, L. Quintanilla-Martinez, M. Kremer, M. Rohde, M. Hogardt, K. Pfeffer, H. Russmann, and W. D. Hardt. 2003. Pretreatment of mice with streptomycin provides a Salmonella enterica serovar Typhimurium colitis model that allows analysis of both pathogen and host. Infect. Immun. 71:2839-2858.
2. Blauvelt, A., H. Asada, V. Klaus-Kovtun, D. J. Altman, D. R. Lucey, and S. I. Katz. 1996. Interleukin-15 mRNA is expressed by human keratinocytes, Langerhans cells, and blood-derived dendritic cells and is downregulated by ultraviolet B radiation. J. Investig. Dermatol. 106:1047-1052.
3. Brigl, M., L. Bry, S. C. Kent, J. E. Gumperz, and M. B. Brenner. 2003. Mechanism of CD1d-restricted natural killer T cell activation during microbial infection. Nat. Immunol. 4:1230-1237.
4. Carson, W. E., J. G. Giri, M. J. Lindemann, M. L. Linett, M. Ahdieh, R. Paxton, D. Anderson, J. Eisenmann, K. Grabstein, and M. A. Caligiuri. 1994. Interleukin (IL) 15 is a novel cytokine that activates human natural killer cells via components of the IL-2 receptor. J. Exp. Med. 180:1395-1403.
5. Carson, W. E., M. E. Ross, R. A. Baiocchi, M. J. Marien, N. Boiani, K. Grabstein, and M. A. Caligiuri. 1995. Endogenous production of interleukin 15 by activated human monocytes is critical for optimal production of interferon-gamma by natural killer cells in vitro. J. Clin. Investig. 96:2578-2582.
6. Coburn, B., Y. Li, D. Owen, B. A. Vallance, and B. B. Finlay. 2005. Salmonella enterica serovar Typhimurium pathogenicity island 2 is necessary for complete virulence in a mouse model of infectious enterocolitis. Infect. Immun. 73:3219-3227.
7. Coombes, B. K., B. A. Coburn, A. A. Potter, S. Gomis, K. Mirakhur, Y. Li, and B. B. Finlay. 2005. Analysis of the contribution of Salmonella pathogenicity islands 1 and 2 to enteric disease progression using a novel bovine ileal loop model and a murine model of infectious enterocolitis. Infect. Immun. 73:7161-7169.
8. Coombes, B. K., Y. Valdez, and B. B. Finlay. 2004. Evasive maneuvers by secreted bacterial proteins to avoid innate immune responses. Curr. Biol. 14:R856-R867.
9. Doherty, T. M., R. A. Seder, and A. Sher. 1996. Induction and regulation of IL-15 expression in murine macrophages. J. Immunol. 156:735-741.
10. European Commission. 2007. Surveillance of enteric pathogens in Europe and beyond: international surveillance network for the enteric infections - Salmonella, VTEC O157 and Campylobacter. 1786/2002/EC. European Commission, Brussels, Belgium. http://ecdc.europa.eu/en/files/pdf/Activities/ ENTER-NET/annual-report2005.pdf.
11. Fehniger, T. A., and M. A. Caligiuri. 2001. Interleukin 15: biology and relevance to human disease. Blood 97:14-32.
12. Finlay, B. B., and R. E. Hancock. 2004. Can innate immunity be enhanced to treat microbial infections? Nat. Rev. Microbiol. 2:497-504.
13. Gajendran, N., H. W. Mittrucker, K. Bordasch, E. Heinemann, M. Koch, and S. H. Kaufmann. 2007. Regional IFN-gamma expression is insufficient for efficacious control of food-borne bacterial pathogens at the gut epithelial barrier. Int. Immunol. 19:1075-1081.
14. Gill, N., P. M. Deacon, B. Lichty, K. L. Mossman, and A. A. Ashkar. 2006. Induction of innate immunity against herpes simplex virus type 2 infection via local delivery of Toll-like receptor ligands correlates with beta interferon production. J. Virol. 80:9943-9950.
15. Hancock, R. E., and H. G. Sahl. 2006. Antimicrobial and host-defense peptides as new anti-infective therapeutic strategies. Nat. Biotechnol. 24:1551-1557.
16. Hapfelmeier, S., K. Ehrbar, B. Stecher, M. Barthel, M. Kremer, and W. D. Hardt. 2004. Role of the Salmonella pathogenicity island 1 effector proteins SipA, SopB, SopE, and SopE2 in Salmonella enterica subspecies 1 serovar Typhimurium colitis in streptomycin-pretreated mice. Infect. Immun. 72:795-809.
17. Harrington, L., C. V. Srikanth, R. Antony, H. N. Shi, and B. J. Cherayil. 2007. A role for natural killer cells in intestinal inflammation caused by infection with Salmonella enterica serovar Typhimurium. FEMS Immunol. Med. Microbiol. 51:372-380.
18. Helms, M., S. Ethelberg, and K. Molbak. 2005. International Salmonella Typhimurium DT104 infections, 1992-2001. Emerg. Infect. Dis. 11:859-867.
19. Helms, M., P. Vastrup, P. Gerner-Smidt, and K. Molbak. 2002. Excess mortality associated with antimicrobial drug-resistant Salmonella typhimurium. Emerg. Infect. Dis. 8:490-495.
20. Hiromatsu, T., T. Yajima, T. Matsuguchi, H. Nishimura, W. Wajjwalku, T. Arai, Y. Nimura, and Y. Yoshikai. 2003. Overexpression of interleukin-15 protects against Escherichia coli-induced shock accompanied by inhibition of tumor necrosis factor-alpha-induced apoptosis. J. Infect. Dis. 187:1442-1451.
21. Hirose, K., H. Nishimura, T. Matsuguchi, and Y. Yoshikai. 1999. Endogenous IL-15 might be responsible for early protection by natural killer cells against infection with an avirulent strain of Salmonella choleraesuis in mice. J. Leukoc. Biol. 66:382-390.
22. Jonuleit, H., K. Wiedemann, G. Muller, J. Degwert, U. Hoppe, J. Knop, and A. H. Enk. 1997. Induction of IL-15 messenger RNA and protein in human blood-derived dendritic cells: a role for IL-15 in attraction of T cells. J. Immunol. 158:2610-2615.
23. Kennedy, M. K., M. Glaccum, S. N. Brown, E. A. Butz, J. L. Viney, M. Embers, N. Matsuki, K. Charrier, L. Sedger, C. R. Willis, K. Brasel, P. J. Morrissey, K. Stocking, J. C. Schuh, S. Joyce, and J. J. Peschon. 2000. Reversible defects in natural killer and memory CD8 T cell lineages in interleukin 15-deficient mice. J. Exp. Med. 191:771-780.
24. Kirby, A. C., U. Yrlid, and M. J. Wick. 2002. The innate immune response differs in primary and secondary Salmonella infection. J. Immunol. 169:4450-4459.
25. Kirman, I., and O. H. Nielsen. 1996. Increased numbers of interleukin-15-expressing cells in active ulcerative colitis. Am. J. Gastroenterol. 91:1789-1794.
26. Lauzon, N. M., F. Mian, R. MacKenzie, and A. A. Ashkar. 2006. The direct effects of Toll-like receptor ligands on human NK cell cytokine production and cytotoxicity. Cell. Immunol. 241:102-112.
27. Liu, Z., K. Geboes, S. Colpaert, G. R. D'Haens, P. Rutgeerts, and J. L. Ceuppens. 2000. IL-15 is highly expressed in inflammatory bowel disease and regulates local T cell-dependent cytokine production. J. Immunol. 164:3608-3615.
28. Lo, C. K., Q. L. Lam, L. Sun, S. Wang, K. H. Ko, H. Xu, C. Y. Wu, B. J. Zheng, and L. Lu. 2008. Natural killer cell degeneration exacerbates experimental arthritis in mice via enhanced interleukin-17 production. Arthritis Rheum. 58:2700-2711.
29. Lodolce, J. P., D. L. Boone, S. Chai, R. E. Swain, T. Dassopoulos, S. Trettin, and A. Ma. 1998. IL-15 receptor maintains lymphoid homeostasis by supporting lymphocyte homing and proliferation. Immunity 9:669-676.
30. Lupp, C., M. L. Robertson, M. E. Wickham, I. Sekirov, O. L. Champion, E. C. Gaynor, and B. B. Finlay. 2007. Host-mediated inflammation disrupts the intestinal microbiota and promotes the overgrowth of Enterobacteriaceae. Cell Host Microbe 2:119-129.
31. Martin, L. J., M. Fyfe, K. Dore, J. A. Buxton, F. Pollari, B. Henry, D. Middleton, R. Ahmed, F. Jamieson, B. Ciebin, S. A. McEwen, and J. B. Wilson. 2004. Increased burden of illness associated with antimicrobial-resistant Salmonella enterica serotype typhimurium infections. J. Infect. Dis. 189:377-384.
32. Mizuno, Y., H. Takada, A. Nomura, C. H. Jin, H. Hattori, K. Ihara, T. Aoki, K. Eguchi, and T. Hara. 2003. Th1 and Th1-inducing cytokines in Salmonella infection. Clin. Exp. Immunol. 131:111-117.
33. Morens, D. M., G. K. Folkers, and A. S. Fauci. 2004. The challenge of emerging and re-emerging infectious diseases. Nature 430:242-249.
34. Naiki, Y., H. Nishimura, T. Kawano, Y. Tanaka, S. Itohara, M. Taniguchi, and Y. Yoshikai. 1999. Regulatory role of peritoneal NK1.1+ alpha beta T cells in IL-12 production during Salmonella infection. J. Immunol. 163:2057-2063.
35. National Academy of Sciences. 2006. Treating infectious diseases in a microbial world: report on two workshops on novel antimicrobial therapeutics. National Academy of Sciences 0-309-65490-4. National Academies Press, Washington, DC.
36. Nishimura, H., M. Tagaya, H. Tsunobuchi, H. Suzuki, I. Nakashima, and Y. Yoshikai. 2001. Mice lacking interleukin-2 (IL-2)/IL-15 receptor beta chain are susceptible to infection with avirulent Salmonella enterica subsp. enterica serovar Choleraesuis, but mice lacking IL-2 are resistant. Infect. Immun. 69:1226-1229.
37. Ogawa, T., Y. Asai, R. Tamai, Y. Makimura, H. Sakamoto, S. Hashikawa, and K. Yasuda. 2006. Natural killer cell activities of synbiotic Lactobacillus casei ssp. casei in conjunction with dextran. Clin. Exp. Immunol. 143:103-109.
38. Raffatellu, M., R. L. Santos, D. E. Verhoeven, M. D. George, R. P. Wilson, S. E. Winter, I. Godinez, S. Sankaran, T. A. Paixao, M. A. Gordon, J. K. Kolls, S. Dandekar, and A. J. Baumler. 2008. Simian immunodeficiency virus-induced mucosal interleukin-17 deficiency promotes Salmonella dissemination from the gut. Nat. Med. 14:421-428.
39. Sakai, T., K. Kusugami, H. Nishimura, T. Ando, T. Yamaguchi, M. Ohsuga, K. Ina, A. Enomoto, Y. Kimura, and Y. Yoshikai. 1998. Interleukin 15 activity in the rectal mucosa of inflammatory bowel disease. Gastroenterology 114:1237-1243.
40. Scott, M. G., E. Dullaghan, N. Mookherjee, N. Glavas, M. Waldbrook, A. Thompson, A. Wang, K. Lee, S. Doria, P. Hamill, J. J. Yu, Y. Li, O. Donini, M. M. Guarna, B. B. Finlay, J. R. North, and R. E. Hancock. 2007. An anti-infective peptide that selectively modulates the innate immune response. Nat. Biotechnol. 25:465-472.
41. Sekirov, I., N. M. Tam, M. Jogova, M. L. Robertson, Y. Li, C. Lupp, and B. B. Finlay. 2008. Antibiotic-induced perturbations of the intestinal microbiota alter host susceptibility to enteric infection. Infect. Immun. 76:4726-4736.
42. Stecher, B., and W. D. Hardt. 2008. The role of microbiota in infectious disease. Trends Microbiol. 16:107-114.
43. Stecher, B., R. Robbiani, A. W. Walker, A. M. Westendorf, M. Barthel, M. Kremer, S. Chaffron, A. J. Macpherson, J. Buer, J. Parkhill, G. Dougan, C. von Mering, and W. D. Hardt. 2007. Salmonella enterica serovar typhimurium exploits inflammation to compete with the intestinal microbiota. PLoS Biol. 5:2177-2189.
44. Umemura, M., H. Nishimura, K. Hirose, T. Matsuguchi, and Y. Yoshikai. 2001. Overexpression of IL-15 in vivo enhances protection against Mycobacterium bovis bacillus Calmette-Guerin infection via augmentation of NK and T cytotoxic 1 responses. J. Immunol. 167:946-956.
45. Worley, M. J., G. S. Nieman, K. Geddes, and F. Heffron. 2006. Salmonella typhimurium disseminates within its host by manipulating the motility of infected cells. Proc. Natl. Acad. Sci. USA USA 103:17915- 17920.
46. Yajima, T., H. Nishimura, R. Ishimitsu, K. Yamamura, T. Watase, D. H. Busch, E. G. Pamer, H. Kuwano, and Y. Yoshikai. 2001. Memory phenotype CD8(+) T cells in IL-15 transgenic mice are involved in early protection against a primary infection with Listeria monocytogenes. Eur. J. Immunol. 31:757-766.
47. Yajima, T., H. Nishimura, W. Wajjwalku, M. Harada, H. Kuwano, and Y. Yoshikai. 2002. Overexpression of interleukin-15 in vivo enhances antitumor activity against MHC class I-negative and -positive malignant melanoma through augmented NK activity and cytotoxic T-cell response. Int. J. Cancer 99:573-578.
48. Yoshihara, K., T. Yajima, C. Kubo, and Y. Yoshikai. 2006. Role of interleukin 15 in colitis induced by dextran sulphate sodium in mice. Gut 55:334-341.